BioStem Technologies, Inc. (OTC Pink: BSEM) Begins Construction of New Laboratory Facility
July 13 2016 - 8:53AM
Marketwired
BioStem Technologies, Inc. (OTC Pink: BSEM) Begins Construction
of New Laboratory Facility
OAKLAND PARK, FL-(Marketwired - Jul 13, 2016) - BioStem
Technologies, Inc. (OTC PINK: BSEM) (the "Company" or "BioStem")
announced today the commencement of construction of the Company's
new pharmaceutical grade laboratory facility. Biostem's
pharmaceutical and nutraceutical operations have expanded rapidly
since the change of control in late 2014, and the Company has
revised its original plans for the facility to include less office
space and more 'small batch' manufacturing rooms and general
laboratory space.
The new, state-of-the-art facility will house multiple general
labs, clean rooms, and small batch manufacturing rooms to support
production and development of pharmaceutical, nutraceutical and
cell based products. The facility will also be open for industrial
and educational tours as a way of furthering BioStem's integrated
mission of science, education and exhibition of the vast array of
opportunities and benefits that are available to mankind through
stem cell and nutritional products.
"This facility will give our scientists and researchers the
laboratory resources they need to rapidly develop new products.
We're looking forward to streamlining our developmentment and
manufacturing processes, and to having the ability to test efficacy
of these compounds in-house" said Andrew Van Vurst, COO of BioStem
Technologies.
About BioStem Technologies, Inc. (OTC PINK: BSEM): BioStem
Technologies (OTC PINK: BSEM) is in the business of regenerative
medicine and antiaging strategies throughout the United States,
Europe, and Mexico. The Company's mission is to conquer the effects
of biological aging (and related acute disease), and its strategy
is to discover, develop, produce, and deliver the most effective
stem cell and wellness products in the world. The Company is
comprised of a diverse group of scientists, physicians, and
industry visionaries who are creating innovative products for
helping customers live their best, feel their best, and be their
best. The company operates four strategic business units - BioStem
Cell Therapy, BioStem Wellness, BioStem Pharmaceuticals, and
BioStem International - providing a diversified line of products
and services that include: clinical stem cell therapy, stem cell
R&D, state-of-the-art laboratory services, pharmaceuticals,
nutraceuticals, cosmeceuticals, API Repackaging, and medical
tourism.
Forward-Looking Statements: Except for statements of historical
fact, the matters discussed in this press release are forward
looking and made pursuant to the Safe Harbor provisions of the
Private Securities Litigation Reform Act of 1995. "Forward-looking
statements" describe future expectations, plans, results, or
strategies and are generally preceded by words such as "future,"
"plan" or "planned," "expects," believe" or "projected." These
forward-looking statements reflect numerous assumptions and involve
a variety of risks and uncertainties, many of which are beyond the
company's control that may cause actual results to differ
materially from stated expectations. These risk factors include,
among others, limited operating history, difficulty in developing,
exploiting and protecting proprietary technologies, intense
competition and additional risks factors as discussed in reports
filed by the company with OTC Markets.
Contact:BioStem Technologies, Inc.Phone: 954-380-8342Website:
http://www.biostemtech.comEmail: info@biostemtech.comTwitter:
@BiostemtechFacebook: BioStem Technologies
BioStem Technologies (PK) (USOTC:BSEM)
Historical Stock Chart
From Dec 2024 to Jan 2025
BioStem Technologies (PK) (USOTC:BSEM)
Historical Stock Chart
From Jan 2024 to Jan 2025
